Abbott Laboratories
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Asset Breakdown FY2011
Total Assets: $60.28B
Liabilities Breakdown FY2011
Total Liabilities: $35.84B
Asset Breakdown
Total Assets: $60.28B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $6.81B | 11.3% |
| Accounts Receivable | $7.68B | 12.7% |
| Inventory | $3.28B | 5.4% |
| Property, Plant & Equipment | $7.87B | 13.1% |
| Goodwill | $15.71B | 26.1% |
| Intangible Assets | $9.99B | 16.6% |
| Other Assets | $8.93B | 14.8% |
Liabilities Breakdown
Total Liabilities: $35.84B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.72B | 4.8% |
| Long-Term Debt | $12.04B | 33.6% |
| Other Liabilities | $22.08B | 61.6% |